Efficacy and Safety of Benidipine Therapy of Essential Hypertension in Elderly Chinese Patients

Abstract

Background:

Benidipine (CAS 105979-17-7) is a dihydropyridine calcium channel blocker used in the treatment of hypertension and angina pectoris.

Objective:

To examine the efficacy and safety of therapy with benidipine in elderly hypertensive patients.

Methods:

Chinese patients > 60 years of age with mild to moderate essential hypertension were enrolled. The patients were prescribed benidipine at the dose of 8 mg once daily for 12 weeks. Detailed laboratory examinations and 24-h ambulatory blood pressure monitoring were performed before and after the treatment.

Results:

One hundred and sixty-four of the 180 patients enrolled completed the 12-week active treatment phase. Sitting systolic blood pressure (SBP) and diastolic blood pressure (DBP) reductions at the end of treatment were 21.50 ± 12.83 and 10.60 ± 8.04 mmHg, respectively; the proportion of patients showing a good treatment response was 95.1% for SBP and 96.9% for DBP. Benidipine significantly reduced the mean 24-h ambulatory blood pressure (p<0.001 vs. baseline) exhibiting smooth, sustained effects and high trough-to-peak ratios (T/P ratio) (0.87 for SBP and 0.72 for DBP). Moreover, benidipine significantly reduced the systolic morning blood pressure surge and urinary albumin, and it was well tolerated. No serious adverse events were noted.

Conclusion:

Benidipine was well tolerated and effective in elderly Chinese patients with essential hypertension.

Key words

Antihypertensives - Benidipine, efficacy, safety - Calcium channel blockers, dihydropyridine - CAS 105979-17-7

• References

• 1 Yamashita T, Kawashima S, Ozaki M, Rikitake Y, Hirase T, Inoue N et al. A calcium channel blocker, benidipine, inhibits intimal thickening in the carotid artery of mice by increasing nitric oxide production. J Hypertens. 2001; 19: 451-458
• 2 Saito F, Fujita H, Takahashi A, Ichiyama I, Harasawa S, Oiwa K. Renoprotective effect and cost-effectiveness of using benidipine, a calcium channel blocker, to lower the dose of angiotensin receptor blocker in hypertensive patients with albuminuria. Hypertens Res. 2007; 30: 39-47
• 3 Tsuda K, Nishio I. A calcium channel blocker, benidipine, improves cell membrane fluidity in human subjects via a nitric oxide-dependent mechanism. An electron paramagnetic resonance investigation. Am J Hypertens. 2004; 17: 1143-1150
• 4 Suzuki H, Yokoyama K, Akimoto Y, Daida H. Clinical efficacy of benidipine for vasospastic angina pectoris. Arzneimittel-Forschung (Drug Research). 2007; 57: 20-5
• 5 Li Y, Wang JG, Dolan E, Gao PJ, Guo HF, Nawrot T et al. Ambulatory arterial stiffness index derived from 24-hour ambulatory blood pressure monitoring. Hypertension. 2006; 47: 359-364
• 6 Manfredini R, Boari B, Portaluppi F. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives. Circulation. 2003; 108: e72-73
• 7 Tseng YZ. Applications of 24-hour noninvasive ambulatory blood pressure monitoring. J Formos Med Assoc. 2006; 105: 955-963
• 8 Parati G, Omboni S, Rizzoni D, Agabiti-Rosei E, Mancia G. The smoothness index: a new, reproducible and clinically relevant measure of the homogeneity of the blood pressure reduction with treatment for hypertension. J Hypertens. 1998; 16: 1685-1691
• 9 Pickering TG, Coats A, Mallion JM, Mancia G, Verdecchia P. Blood Pressure Monitoring. Task Force V: White-coat hypertension. Blood Press Monit. 1999; 4: 333-341
• 10 Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002; 360: 1903-1913
• 11 Veerman DP, de Blok K, van Montfrans A. Relationship of steady state and ambulatory blood pressure variability to left ventricular mass and urinary albumin excretion in essential hypertension. Am J Hypertens. 1996; 9: 455-460
• 12 Nakajima O, Akioka H, Miyazaki M. Effect of the calcium antagonist benidipine hydrochloride on 24-h ambulatory blood pressure in patients with mild to moderate hypertension in a double-blind study against placebo. Arzneimittel-Forschung (Drug Research). 2000; 50: 620-625
• 13 Wang F, Kan LM, Huang J, Wang L, Bian WY, Chen XR et al. Effect of Benidipine hydrochloride on blood pressure in patients with hypertension assessed by ambulatory blood pressure. Chin J Hypertens. 2004; 12: 303-306
• 14 Willich SN, Levy D, Rocco MB, Tofler GH, Stone PH, Muller JE. Circadian variation in the incidence of sudden cardiac death in the Framingham Heart Study population. Am J Cardiol. 1987; 60: 801-806
• 15 Kario K, Shimada K, Pickering TG. Clinical implication of morning blood pressure surge in hypertension. J Cardiovasc Pharmacol. 2003; 42: S87-91
• 16 Kita T, Suzuki Y, Eto T, Kitamura K. Long-term anti-hypertensive therapy with benidipine improves arterial stiffness over blood pressure lowering. Hypertens Res. 2005; 28: 959-64
• 17 Uzu T, Nishimura M, Fujii T, Sakaguchi M, Kanasaki M, Isshiki K. Benidipine attenuates glomerular hypertension and reduces albuminuria in patients with metabolic syndrome. Hypertens Res. 2007; 30: 161-165